肝肺综合征的诊治现状  

Current diagnosis and therapy of hepatopulmonary syndrome

作　　者：胡志坚[1] 柏立山[1] 柴新群[1] 

机构地区：[1]华中科技大学同济医学院附属协和医院肝胆外科,武汉430022

出　　处：《国际外科学杂志》2012年第1期34-39,共6页International Journal of Surgery

基　　金：国家自然科学基金资助项目（No.81070059）

摘　　要：肝肺综合征是因慢性肝脏疾病、肺内血管扩张引起的动静脉分流和低氧血症为特征的肺部综合性疾病。由于诊病发病机制复杂，发病隐匿，缺乏特异性临床表现，不易早期诊断，确诊时患者病情多较重。目前其临床治疗方法及疗效有限，预后差，本文就肝肺综合征的诊治现状作一综述。Hepatopulmonary syndrome is a pulmonary syndrome that is characterized by the clinical triad of chronic liver disease, arteriovenous shunts due to intrapulmonary vasodilatation, and arterial hypoxemia. Dwing to its complicated pathogenisis, uneonspieuous behavior and lack of clinic features, it is very hard for early diagnosis, so while diagnosed, most of HPS patients are in a havd way. The clinical treatment is limited with unsatisfactory effectiveness, so does the prognosis. This article reviews the current diagnosis and therapies of hepatopulmonary syndrome.

关 键 词：肝肺综合征 低氧血症 原位肝移植 

分 类 号：R575[医药卫生—消化系统]